Masterclass in Vilnius — Regenerative Therapies in Male Andrology

Register Now

Prof. Dimitris Hatzichristou

Uro-Andrology, MD PhD (Thessaloniki, Greece)

Join Prof Dimitris HATZICHRISTOU (Greece) on an in-depth journey combining over 30 years of clinical experience treating some twenty thousand patients.

On 24 October 2025, the Lithuanian capital, Vilnius, will host one of the highlights of the 2025 Sexual Medicine Masterclass series, organised by BioBridge. This one-day training is dedicated to the latest advances in regenerative andrology, with a particular focus on minimally invasive treatments for erectile dysfunction and Peyronie’s disease.

Objectives & theme
The Vilnius Masterclass combines scientific insight with practical guidance, offering participants an integrated perspective on modern therapeutic options in uro-andrology. Key topics will include:

  • The scientific foundations of biological therapies (particularly platelet-rich plasma – PRP)

  • Clinical application of regenerative therapies alone or in combination (PRP + traction devices, PRP + shockwave therapy)

  • Contemporary protocols for the management of Peyronie’s disease and erectile dysfunction

  • Practical advice, clinical pearls, and real-world experience

By the end of the day, participants will not only understand the evidence base but also gain hands-on knowledge and practical “tips & tricks” to implement in their own clinical setting.

Key faculty
The course will be led by Prof. Dimitris Hatzichristou (Greece), a recognised authority in uro-andrology with over 30 years of clinical expertise and nearly 20,000 patients treated. His extensive experience ensures a deep dive into both the biological and practical aspects of regenerative treatments.

Target audience & registration
This masterclass is designed for urologists, andrologists, reproductive medicine specialists, and healthcare professionals interested in integrating regenerative strategies into their practice.
Registration details (venue, fees, programme) can be obtained by completing the request form on the BioBridge website.
As places are limited, early registration is strongly recommended.

Conclusion
The Vilnius Masterclass offers a unique opportunity for clinicians to update their knowledge and acquire hands-on insights into regenerative approaches for male sexual health. Secure your place now and join an international community of experts shaping the future of andrology.

If you're interested in joining a masterclass, complete the form below to receive all the details for registration

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.